Free Access
Med Sci (Paris)
Volume 24, Number 5, Mai 2008
Page(s) 491 - 498
Section M/S revues
Published online 15 May 2008
  1. Maridonneau-Parini I, Daffé M. Tropisme tissulaire des mycobactéries. Med Sci (Paris) 2001; 17 : 388–93. [Google Scholar]
  2. WHO. Global leprosy situation. Wkly Epidemiol Rec 2006; 81 : 309–16. [Google Scholar]
  3. Britton WJ, Lockwood DN. Leprosy. Lancet 2004; 363 : 1209–19. [Google Scholar]
  4. Convit J, Sampson C, Zuniga M, et al. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy : preliminary results. Lancet 1992; 339 : 446–50. [Google Scholar]
  5. Chaudhury S, Hazra SK, Saha B, et al. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis. Int J Lepr Other Mycobact Dis 1994; 62 : 389–94. [Google Scholar]
  6. Gupte MD, Vallishayee RS, Anantharaman DS, et al. Comparative leprosy vaccine trial in south India. Indian J Lepr 1998; 70 : 369–88. [Google Scholar]
  7. Monot M, Honore N, Garnier T, et al. On the origin of leprosy. Science 2005; 308 : 1040–2. [Google Scholar]
  8. Alcais A, Abel L. Application of genetic epidemiology to dissecting host susceptibility/resistance to infection illustrated with the study of common mycobacterial infections. In : Bellamy RE, ed. Susceptibility to infectious diseases : the importance of host genetics. Cambridge, UK : Cambridge University Press, 2004 : 7–44. [Google Scholar]
  9. Shields ED, Russell DA, Pericak-Vance MA. Genetic epidemiology of the susceptibility to leprosy. J Clin Invest 1987; 79 : 1139–43. [Google Scholar]
  10. Spickett S. Genetics and the epidemiology of leprosy. II. The form of leprosy. Lepr Rev 1962; 33 : 173–781. [Google Scholar]
  11. Mohamed-Ali P, Ramanujam K. Leprosy in twins. Int J Lepr 1966; 34 : 405–7. [Google Scholar]
  12. Chakravartti M, Vogel F. A twin study on leprosy. In : Becker PE, ed. Topics in human genetics. Stuttgart : Georg Thieme, 1973 : 1–123. [Google Scholar]
  13. Abel L, Demenais F. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island : Desirade island. Am J Hum Genet 1988; 42 : 256–66. [Google Scholar]
  14. Abel L, Lap VD, Oberti J, et al. Complex segregation analysis of leprosy in Southern Vietnam. Genet Epidemiol 1995; 12 : 63–82. [Google Scholar]
  15. Meyer CG, May J, Stark K. Human leukocyte antigens in tuberculosis and leprosy. Trends Microbiol 1998; 6 : 148–54. [Google Scholar]
  16. Mira MT, Alcais A, Di Pietrantonio T, et al. Segregation of HLA/TNF region is linked to leprosy clinical spectrum in families displaying mixed leprosy subtypes. Genes Immun 2003; 4 : 67–73. [Google Scholar]
  17. Mehra NK, Verduijn W, Taneja V, et al. Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population. Hum Immunol 1991; 32 : 246–53. [Google Scholar]
  18. Mehra NK, Rajalingam R, Mitra DK, et al. Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians. Int J Lepr Other Mycobact Dis 1995; 63 : 241–8. [Google Scholar]
  19. Zerva L, Cizman B, Mehra NK, et al. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J Exp Med 1996; 183 : 829–36. [Google Scholar]
  20. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria : the human model. Annu Rev Immunol 2002; 20 : 581–620. [Google Scholar]
  21. Alcais A, Mira M, Casanova JL, et al. Genetic dissection of immunity in leprosy. Curr Opin Immunol 2005; 17 : 44–8. [Google Scholar]
  22. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007; 447 : 655–60. [Google Scholar]
  23. Siddiqui MR, Meisner S, Tosh K, et al. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 2001; 27 : 439–41. [Google Scholar]
  24. Mira MT, Alcais A, Van Thuc N, et al. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 2003; 33 : 412–5. [Google Scholar]
  25. Mira MT, Alcais A, Nguyen VT, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004; 427 : 636–40. [Google Scholar]
  26. Alcais A, Abel L. Identification d’un nouveau gène de susceptibilité à la lèpre par clonage positionnel. Med Sci (Paris) 2004; 20 : 729–32. [Google Scholar]
  27. Malhotra D, Darvishi K, Lohra M, et al. Association study of major risk single nucleotide polymorphisms in the common regulatory region of PARK2 and PACRG genes with leprosy in an Indian population. Eur J Hum Genet 2006; 14 : 438–42. [Google Scholar]
  28. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392 : 605–8. [Google Scholar]
  29. Corti O, Brice A. La maladie de Parkinson : que nous apprennent les genes responsables des formes familiales ? Med Sci (Paris) 2003; 19 : 613–9. [Google Scholar]
  30. Schurr E, Alcais A, de Leseleuc L, Abel L. Genetic predisposition to leprosy : a major gene reveals novel pathways of immunity to Mycobacterium leprae. Semin Immunol 2006; 18 : 404–10. [Google Scholar]
  31. Alcais A, Alter A, Antoni G, et al. Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat Genet 2007; 39 : 517–22. [Google Scholar]
  32. Knight JC, Keating BJ, Kwiatkowski DP. Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Nat Genet 2004; 36 : 394–9. [Google Scholar]
  33. Ware CF. Network communications : lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005; 23 : 787–819. [Google Scholar]
  34. Roach DR, Briscoe H, Saunders B, France MP, Riminton S, Britton WJ. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 2001; 193 : 239–46. [Google Scholar]
  35. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449 : 851–61. [Google Scholar]
  36. Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 2007; 8 : 657–62. [Google Scholar]
  37. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314 : 1461–3. [Google Scholar]
  38. Bleharski JR, Li H, Meinken C, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003; 301 : 1527–30. [Google Scholar]
  39. Ranque B, Alcais A, Thuc NV, et al. A recessive major gene controls the mitsuda reaction in a region endemic for leprosy. J Infect Dis 2005; 192 : 1475–82. [Google Scholar]
  40. Ranque B, Alter A, Mira M, et al. Genomewide linkage analysis of the granulomatous mitsuda reaction implicates chromosomal regions 2q35 and 17q21. J Infect Dis 2007; 196 : 1248–52. [Google Scholar]
  41. Ranque B, Thuc NV, Thai VH, et al. Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese leprosy patients. Clin Infect Dis 2007; 44 : 33–40. [Google Scholar]
  42. Alonso S, Pethe K, Russell DG, Purdy GE. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc Natl Acad Sci USA 2007; 104 : 6031–6. [Google Scholar]
  43. Fulco TO, Lopes UG, Sarno EN, et al. The proteasome function is required for Mycobacterium leprae-induced apoptosis and cytokine secretion. Immunol Lett 2007; 110 : 82–5. [Google Scholar]
  44. Ali S, Vollaard AM, Widjaja S, et al. PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever. Clin Exp Immunol 2006; 144 : 425–31. [Google Scholar]
  45. Quintana-Murci L, Alcais A, Abel L, Casanova JL. Immunology in natura : clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 2007; 8 : 1165–71. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.